Absolute game changer for women going through this really tense and difficult period- it gives you back a sense if control.”
With CHLOE, patients can see directly into the lab and incubator, creating a meaningful connection to their embryos from the very start.
CHLOE Patients allows you to:

See every moment
from the first cell

Be part of your embryo culture period

Understand how your embryos grow

Share with your partner
See Clearly: Transparent Access, Embryo Viewing, and Insightful Reports
Dr Cristina Hickman,
Founder
at Avenues
Dr Laura Rienzi,
Director of the Scientific Executive Committee of GeneraLife, Associate Professor @University of Urbino “Carlo Bo”, Italy
Most patients would like to receive regular updates and more detailed explanations – study shows
90% of patients state that they would like to receive regular updates and detailed explanation from their doctor, yet this happened in only half of the cases
![]()
Fairtility Launches CHLOE OQ, A New AI-Powered Fertility Preservation Offer (femtechinsider.com)
CHLOE OQ, which has also received CE certification, now brings AI-powered assessment to oocyte evaluation, replacing subjective decision-making with personalized, data-driven analysis. It stands to enhance decision-making across three key areas: egg freezing, egg donation, and IVF treatment.
![]()
New AI Fertility Tool Optimizes Reproductive Potential (nocamels.com)
Oocyte potential prediction for reaching blastulation and pregnancy commonly relies on statistical methods based on a woman’s age. Embryologists analyze oocyte quality based on oocyte maturity and characteristics including size, texture, shape, discoloration and fragmentation. These factors have proven to be subjective and lack correlation with the actual quality of the egg, according to ESHRE.